A Multidisciplinary Perspective Addressing the Diagnostic Challenges of Late-Onset Pompe Disease in the Arabian Peninsula Region Developed From an Expert Group Meeting
- PMID: 35754286
- PMCID: PMC9535603
- DOI: 10.3233/JND-220819
A Multidisciplinary Perspective Addressing the Diagnostic Challenges of Late-Onset Pompe Disease in the Arabian Peninsula Region Developed From an Expert Group Meeting
Abstract
Pompe disease is a rare, metabolic, autosomal recessive disorder. Early diagnosis is critical for progressive Pompe disease as delays can significantly alter the clinical course of the disease. Diagnostic modalities, including dried blood spot testing and genetic testing, are available and are effective for diagnosing patients with late-onset Pompe disease (LOPD). However, clinicians face numerous clinical challenges related to the diagnosis of the disease. Two expert group committee meetings, involving 11 experts from the United Arab Emirates, Kuwait, the Kingdom of Saudi Arabia, and Oman, were convened in October 2019 and November 2020 respectively to develop a uniform diagnostic algorithm for the diagnosis of pediatric and adult LOPD in the Arabian Peninsula region. During the first meeting, the specialty-specific clinical presentation of LOPD was defined. During the second meeting, a diagnostic algorithm was developed after a thorough validation of clinical presentation or symptoms, which was performed with the aid of existing literature and expert judgement. A consensus was reached on the diagnostic algorithm for field specialists, such as neurologists, rheumatologists, general practitioners/internal medicine specialists, orthopedic specialists, and pulmonologists. This specialty-specific diagnostic referral algorithm for pediatric and adult LOPD will guide clinicians in the differential diagnosis of LOPD.
Keywords: Arabian Peninsula region; Late-onset Pompe disease; acid alpha-glucosidase; dried blood spot.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- McCall AL, Salemi J, Bhanap P, Strickland LM, Elmallah MK, The impact of Pompe disease on smooth muscle: A review. J Smooth Muscle Res. 2018;54:100–18. doi: https://doi.org/10.1540/jsmr.54.100. - DOI - PMC - PubMed
-
- Taverna S, Cammarata G, Colomba P, Sciarrino S, Zizzo C, Francofonte D, et al.., Pompe disease: Pathogenesis, molecular genetics and diagnosis. Aging (Albany NY). 2020;12:15856–74. doi: https://doi.org/10.18632/aging.103794. - DOI - PMC - PubMed
-
- Meena NK, Raben N, Pompe Disease: New Developments in an Old Lysosomal Storage Disorder. Biomolecules. 2020;10:1339. doi: https://doi.org/10.3390/biom10091339. - DOI - PMC - PubMed
-
- Feeney EJ, Austin S, Chien YH, The value of muscle biopsies in Pompe disease: Identifying lipofuscin inclusions in juvenile- and adult-onset patients. Acta Neuropathol Commun. 2014;2:2. doi: https://doi.org/10.1186/2051-5960-2-2. - DOI - PMC - PubMed
-
- Toscano A, Rodolico C, Musumeci O, Multisystem late onset Pompe disease (LOPD): An update on clinical aspects. Ann Transl Med. 2019;7:284. doi: https://doi.org/10.21037/atm.2019.07.24. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
